Treatment of acquired transthyretin amyloidosis in domino liver transplantation.

Clinical transplantation(2023)

引用 1|浏览26
暂无评分
摘要
The case presented here supports the concept that patisiran can target the hepatocytes producing the mutated transthyretin in acquired transthyretin amyloidosis, as efficiently as in hereditary transthyretin amyloidosis (hATTR), and can be used to treat patients with transthyretin amyloidosis after DLT.
更多
查看译文
关键词
RNA interference,amyloidosis,liver transplant,patisiran,transthyretin
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要